Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PDXP | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | ZNF785 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | HIST1H4A | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | ZNF519 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | TCEANC2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | CSNK1G2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | GATS | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | DUSP26 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | SOX11 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
mRNA | ADAM22 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |